235 related articles for article (PubMed ID: 10027390)
1. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
Rimm DL; Caca K; Hu G; Harrison FB; Fearon ER
Am J Pathol; 1999 Feb; 154(2):325-9. PubMed ID: 10027390
[TBL] [Abstract][Full Text] [Related]
2. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
4. Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines.
Pollock PM; Hayward N
Melanoma Res; 2002 Apr; 12(2):183-6. PubMed ID: 11930117
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
6. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Garcia-Rostan G; Tallini G; Herrero A; D'Aquila TG; Carcangiu ML; Rimm DL
Cancer Res; 1999 Apr; 59(8):1811-5. PubMed ID: 10213482
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
[TBL] [Abstract][Full Text] [Related]
8. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
9. Nuclear localization and mutation of beta-catenin in medulloblastomas.
Eberhart CG; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
[TBL] [Abstract][Full Text] [Related]
10. beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.
de Castro J; Gamallo C; Palacios J; Moreno-Bueno G; Rodríguez N; Feliu J; González-Barón M
Virchows Arch; 2000 Dec; 437(6):599-604. PubMed ID: 11193470
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
12. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
13. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
Bellei B; Pacchiarotti A; Perez M; Faraggiana T
Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.
Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T
Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139
[TBL] [Abstract][Full Text] [Related]
15. Cadherins, catenins and APC in pleural malignant mesothelioma.
Abutaily AS; Collins JE; Roche WR
J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
17. Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation.
Doglioni C; Piccinin S; Demontis S; Cangi MG; Pecciarini L; Chiarelli C; Armellin M; Vukosavljevic T; Boiocchi M; Maestro R
Am J Pathol; 2003 Dec; 163(6):2277-87. PubMed ID: 14633602
[TBL] [Abstract][Full Text] [Related]
18. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
19. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
20. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
Saldanha G; Ghura V; Potter L; Fletcher A
Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
